Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.

Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research.

Secrest MH, Platt RW, Dormuth CR, Chateau D, Targownik L, Nie R, Doyle CM, Dell’Aniello S, Filion KB. Extreme restriction design as a method for reducing confounding by indication in pharmacoepidemiologic research. Pharmacoepidemiol Drug Saf. 2020 Jan;29 Suppl 1:26-34.

View All Publications